Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Day One Biopharmaceuticals (DAWN) Interest & Investment Income: 2022-2024

Historic Interest & Investment Income for Day One Biopharmaceuticals (DAWN) over the last 3 years, with Dec 2024 value amounting to $19.7 million.

  • Day One Biopharmaceuticals' Interest & Investment Income fell 14.34% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.4 million, marking a year-over-year increase of 9.12%. This contributed to the annual value of $19.7 million for FY2024, which is 14.63% up from last year.
  • As of FY2024, Day One Biopharmaceuticals' Interest & Investment Income stood at $19.7 million, which was up 14.63% from $17.2 million recorded in FY2023.
  • In the past 5 years, Day One Biopharmaceuticals' Interest & Investment Income ranged from a high of $19.7 million in FY2024 and a low of $4.7 million during FY2022.
  • For the 3-year period, Day One Biopharmaceuticals' Interest & Investment Income averaged around $13.9 million, with its median value being $17.2 million (2023).
  • Data for Day One Biopharmaceuticals' Interest & Investment Income shows a peak YoY surged of 262.14% (in 2023) over the last 5 years.
  • Over the past 3 years, Day One Biopharmaceuticals' Interest & Investment Income (Yearly) stood at $4.7 million in 2022, then skyrocketed by 262.14% to $17.2 million in 2023, then increased by 14.63% to $19.7 million in 2024.